Functional stability of Foxp3+ regulatory T cells

Trends in Molecular Medicine

Volumn 18, Issue 8, 2012, Pages 454-462

  Da Silva Martins, Maria ^a,b   Piccirillo, Ciriaco A ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

AMINO ACID SEQUENCE; CD4+ T LYMPHOCYTE; CELL LINEAGE; DNA METHYLATION; EFFECTOR CELL; HUMAN; IMMUNITY; IMMUNOPATHOLOGY; MICROENVIRONMENT; PROTEIN EXPRESSION; PROTEIN STABILITY; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; T-LYMPHOCYTES, REGULATORY;

EID: 84864388039     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2012.06.001     Document Type: Review

References (110)

1. Wing K., Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 2010, 11:7-13.
2. + regulatory T cells in the control of autoimmunity: in vivo veritas. Curr. Opin. Immunol. 2008, 20:655-662.
3. Sakaguchi S. Regulatory T cells: history and perspective. Methods Mol. Biol. 2011, 707:3-17.
4. Bennett C.L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001, 27:20-21.
5. Chatila T.A., et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 2000, 106:R75-R81.
6. Wildin R.S., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001, 27:18-20.
7. d'Hennezel E., et al. The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 2012, 49:291-302.
8. Rudensky A.Y. Regulatory T cells and Foxp3. Immunol. Rev. 2011, 241:260-268.
9. + regulatory T cells. Nat. Immunol. 2003, 4:330-336.
10. Khattri R., et al. The amount of scurfin protein determines peripheral T cell number and responsiveness. J. Immunol. 2001, 167:6312-6320.
11. Hill J.A., et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 2007, 27:786-800.
12. + natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 2006, 18:1197-1209.
13. Zheng Y., et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007, 445:936-940.
14. Lin W., et al. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 2007, 8:359-368.
15. Gavin M.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007, 445:771-775.
16. Lahl K., et al. Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice. J. Immunol. 2009, 183:5662-5672.
17. Lio C-W.J., Hsieh C.-S. Becoming self-aware: the thymic education of regulatory T cells. Curr. Opin. Immunol. 2011, 23:213-219.
18. Klein L., Jovanovic K. Regulatory T cell lineage commitment in the thymus. Semin. Immunol. 2011, 23:401-409.
19. + regulatory T cells: more of the same or a division of labor?. Immunity 2009, 30:626-635.
20. + regulatory T cells in immune tolerance. Annu. Rev. Immunol. 2012, 30:733-758.
21. Tanoue T., Honda K. Induction of Treg cells in the mouse colonic mucosa: a central mechanism to maintain host-microbiota homeostasis. Semin. Immunol. 2012, 24:50-57.
22. +FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-β dependent but does not confer a regulatory phenotype. Blood 2007, 110:2983-2990.
23. + regulatory T cells in vivo. J. Exp. Med. 2003, 198:249-258.
24. + T cells. Eur. J. Immunol. 2007, 37:129-138.
25. + regulatory T cells in the steady state. J. Exp. Med. 2003, 198:737-746.
26. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 2005, 201:723-735.
27. Hori S., et al. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
28. Zhou X., et al. Plasticity of CD4(+) FoxP3(+) T cells. Curr. Opin. Immunol. 2009, 21:281-285.
29. Hori S. Developmental plasticity of Foxp3+ regulatory T cells. Curr. Opin. Immunol. 2010, 22:575-582.
30. Bailey-Bucktrout S.L., Bluestone J.A. Regulatory T cells: stability revisited. Trends Immunol. 2011, 32:301-306.
31. Hori S. Regulatory T cell plasticity: beyond the controversies. Trends Immunol. 2011, 32:295-300.
32. Lal G., Bromberg J.S. Epigenetic mechanisms of regulation of Foxp3 expression. Blood 2009, 114:3727-3735.
33. Xu L., et al. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J. Immunol. 2007, 178:6725-6729.
34. Williams L.M., Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 2007, 8:277-284.
35. Wan Y.Y., Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007, 445:766-770.
36. Duarte J.H., et al. Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur. J. Immunol. 2009, 39:948-955.
37. Komatsu N., et al. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:1903-1908.
38. Yurchenko E., et al. Inflammation-driven reprogramming of CD4+Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo. PLoS ONE 2012, 7:e35572.
39. Tsuji M., et al. Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science 2009, 323:1488-1492.
40. Murai M., et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 2009, 10:1178-1184.
41. Zhou X., et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 2009, 10:1000-1007.
42. Yang X.O., et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008, 29:44-56.
43. Zhou L., et al. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009, 30:646-655.
44. Liu G., et al. The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat. Immunol. 2009, 10:769-777.
45. Rubtsov Y.P., et al. Stability of the regulatory T cell lineage in vivo. Science 2010, 329:1667-1671.
46. Miyao T., et al. Plasticity of Foxp3+ T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 2012, 36:262-275.
47. Oldenhove G., et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 2009, 31:772-786.
48. Hsieh C.-S., et al. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 2004, 21:267-277.
49. Sharma M.D., et al. Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice. Immunity 2010, 33:942-954.
50. Baecher-Allan C., et al. MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 2006, 176:4622-4631.
51. Ito T., et al. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 2008, 28:870-880.
52. Miyara M., et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009, 30:899-911.
53. d'Hennezel E., et al. Single-cell analysis of the human T regulatory population uncovers functional heterogeneity and instability within FOXP3+ cells. J. Immunol. 2011, 186:6788-6797.
54. Long S.A., Buckner J.H. CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game. J. Immunol. 2011, 187:2061-2066.
55. Miyara M., et al. Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun. Rev. 2011, 10:744-755.
56. Sakaguchi S., et al. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 2010, 10:490-500.
57. Levings M.K., et al. Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity. Adv. Immunol. 2006, 92:119-155.
58. Hoffmann P., et al. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation. Eur. J. Immunol. 2009, 39:1088-1097.
59. Voo K.S., et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4793-4798.
60. Ayyoub M., et al. Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORγτ. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:8635-8640.
61. Beriou G., et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009, 113:4240-4249.
62. Raffin C., et al. Ex vivo IL-1 receptor type I expression in human CD4+ T cells identifies an early intermediate in the differentiation of Th17 from FOXP3+ naive regulatory T cells. J. Immunol. 2011, 187:5196-5202.
63. Hansmann L., et al. Dominant Th2 differentiation of human regulatory T cells upon loss of FOXP3 expression. J. Immunol. 2012, 188:1275-1282.
64. Passerini L., et al. Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability. J. Allergy Clin. Immunol. 2011, 128. 1376-1379.e1.
65. Bovenschen H.J., et al. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J. Invest. Dermatol. 2011, 131:1853-1860.
66. Liu T., et al. Forkhead box P3+ T cells express interleukin-17 in nasal mucosa of patients with both allergic rhinitis and polyposis. Clin. Exp. Immunol. 2011, 163:59-64.
67. Hovhannisyan Z., et al. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 2011, 140:957-965.
68. Kryczek I., et al. IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. J. Immunol. 2011, 186:4388-4395.
69. Mcclymont S.A., et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J. Immunol. 2011, 186:3918-3926.
70. Zheng Y., et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010, 463:808-812.
71. Kim H.-P., Leonard W.J. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J. Exp. Med. 2007, 204:1543-1551.
72. Polansky J.K., et al. DNA methylation controls Foxp3 gene expression. Eur. J. Immunol. 2008, 38:1654-1663.
73. Baron U., et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur. J. Immunol. 2007, 37:2378-2389.
74. Janson P.C.J., et al. FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS ONE 2008, 3:e1612.
75. Gavin M.A., et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:6659-6664.
76. Floess S., et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 2007, 5:e38.
77. Huehn J., et al. Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?. Nat. Rev. Immunol. 2009, 9:83-89.
78. Lal G., et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J. Immunol. 2009, 182:259-273.
79. Chen Q., et al. IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo. J. Immunol. 2011, 186:6329-6337.
80. Koenen H.J.P.M., et al. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008, 112:2340-2352.
81. Jeker L.T., Bluestone J.A. Small RNA regulators of T cell-mediated autoimmunity. J. Clin. Immunol. 2010, 30:347-357.
82. Lu L.-F., et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009, 30:80-91.
83. Cobb B.S., et al. A role for Dicer in immune regulation. J. Exp. Med. 2006, 203:2519-2527.
84. Liston A., et al. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J. Exp. Med. 2008, 205:1993-2004.
85. Zhou L., et al. MicroRNA genes. Ann. N. Y. Acad. Sci. 2008, 1150:72-75.
86. Chong M.M.W., et al. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J. Exp. Med. 2008, 205:2005-2017.
87. Marson A., et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007, 445:931-935.
88. Sauer S., et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7797-7802.
89. Haxhinasto S., et al. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 2008, 205:565-574.
90. Zhou L., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORγτ function. Nature 2008, 453:236-240.
91. Bettelli E., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
92. Wohlfert E.A., et al. GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice. J. Clin. Invest. 2011, 121:4503-4515.
93. Wang Y., et al. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 2011, 35:337-348.
94. Wei G., et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009, 30:155-167.
95. Lee Y.K., et al. Developmental plasticity of Th17 and Treg cells. Curr. Opin. Immunol. 2009, 21:274-280.
96. Riley J.L., et al. Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 2009, 30:656-665.
97. d'Hennezel E., et al. IL-2 as a therapeutic target for the restoration of Foxp3+ regulatory T cell function in organ-specific autoimmunity: implications in pathophysiology and translation to human disease. J. Transl. Med. 2010, 8:113.
98. d'Hennezel E., Piccirillo C. Functional plasticity in human FOXP3 (+) regulatory T cells: implications for cell-based immunotherapy. Hum. Vaccin. Immunother. 2012, 8. in press.
99. Haribhai D., et al. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 2011, 35:109-122.
100. Haribhai D., et al. A central role for induced regulatory T cells in tolerance induction in experimental colitis. J. Immunol. 2009, 182:3461-3468.
101. Wohlfert E., Belkaid Y. Role of endogenous and induced regulatory T cells during infections. J. Clin. Immunol. 2008, 28:707-715.
102. Curiel T.J. Regulatory T cells and treatment of cancer. Curr. Opin. Immunol. 2008, 20:241-246.
103. Belkaid Y., Tarbell K. Regulatory T cells in the control of host-microorganism interactions (*). Annu. Rev. Immunol. 2009, 27:551-589.
104. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 2006, 6:295-307.
105. Nishikawa H., Sakaguchi S. Regulatory T cells in tumor immunity. Int. J. Cancer 2010, 127:759-767.
106. Liu V.C., et al. Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J. Immunol. 2007, 178:2883-2892.
107. Zhou G., Levitsky H.I. Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance. J. Immunol. 2007, 178:2155-2162.
108. Grainger J.R., et al. Microbe-dendritic cell dialog controls regulatory T-cell fate. Immunol. Rev. 2010, 234:305-316.
109. Maizels R.M. Infections and allergy - helminths, hygiene and host immune regulation. Curr. Opin. Immunol. 2005, 17:656-661.
110. Hall J.A., et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 2008, 29:637-649.